Supraglottic Airway Needed To Achieve Ventilation
1 other identifier
observational
54
1 country
1
Brief Summary
The purpose of this research is to compare if insertion of laryngeal mask airway (LMA) vs. use of face mask, will reduce the time needed to achieve adequate ventilation prior to insertion of the breathing tube.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 29, 2021
CompletedFirst Posted
Study publicly available on registry
January 13, 2022
CompletedStudy Start
First participant enrolled
January 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 16, 2023
CompletedJuly 5, 2023
July 1, 2023
1.1 years
December 29, 2021
July 3, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Successful ventilation
Compare time needed to achieve ventilation
Up to 15 minutes during the initial period of intubation.
Secondary Outcomes (1)
Subjective criteria of difficult ventilation and intubation
Up to 30 minutes during the initial period of intubation
Study Arms (2)
Laryngeal Mask Airway
Face Mask
Interventions
Insertion of Laryngeal Mask airway for ventilation or use of Face Mask
Eligibility Criteria
Patients scheduled to undergo elective surgery
You may qualify if:
- BMI ≥ 35.
- Patients willing to participate and provide an informed consent.
- Patients scheduled to undergo an elective surgical procedure including laparoscopic or robotic that requires GETA.
You may not qualify if:
- Patients who require administration of succinylcholine for induction/intubation
- Patients with history of uncontrolled GERD.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Florida
Jacksonville, Florida, 32223, United States
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Klaus Torp, MD
Mayo Clinic
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 29, 2021
First Posted
January 13, 2022
Study Start
January 21, 2022
Primary Completion
February 16, 2023
Study Completion
February 16, 2023
Last Updated
July 5, 2023
Record last verified: 2023-07